Alison co-heads our international life sciences team. 

Alison is recognised as a top regulatory and transactional life science lawyers in Europe and is qualified in England & Wales and the Irish Republic.  She works with mid-sized and large pharmaceutical and medical device manufacturers, helping them to design new product offerings to meet regulatory requirements and to facilitate product commercialisation across the UK and EU.  Alison frequently negotiates optimal positions for pharma and medical device companies with regulators such as competent authorities, notified bodies, and industry bodies with voluntary codes.

Alison’s analytical understanding of strategy and business, which comes from over 25 years helping hundreds of life sciences companies manage the range of legal challenges that arise in putting medicinal products and medical devices on the market has encompassed corporate, competition, IP and compliance with anti-bribery laws and codes.  She applies this breadth of knowledge to help companies achieve their business goals at the same time as regulatory and compliance requirements and she is consequently known for providing highly pragmatic advice.

Alison's recent experience includes advising:

  • A pharmaceutical company on gearing up with sales agreements and compliance activities before placing their pharmaceutical and device on the market across Europe.
  • On the VPAS scheme and in particular regarding the size of the rebates payable under it.
  • A pharmaceutical company on responding to a PMCPA complaint.
  • An IVD company on interactions with the MHRA and with government departments:  steering a course to settle regulatory issues on a commercially acceptable basis.

Thomson Reuters, Stand-out Lawyers 2022 - Identified by in-house lawyers as one whom they rated above all others that they interact with.

CV ansehen CV ausblenden

Aktuelle News & Insights

Life Sciences & Healthcare

The EU MDR extension explained – next steps for manufacturers

10. Januar 2023
Briefing

von Alison Dennis

Klicken Sie hier für Details
Life Sciences & Healthcare

Transitional periods, extensions and derogations – help for manufacturers waiting for their MDR certificates

12. Dezember 2022

von Alison Dennis

Klicken Sie hier für Details
Life Sciences & Healthcare

Proposal for an extension of transition times for the EU MDR

8. Dezember 2022

von Alison Dennis

Klicken Sie hier für Details
Interface - Predictions 2023

2023: life sciences and healthcare predictions

Alison Dennis, Nick Vollers and Paul England look at what 2023 holds for life sciences and healthcare.

5. Dezember 2022

von mehreren Autoren

4 von 6 Insights

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.